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Abstract: Oxidative stress is believed to be a major contributory factor in the development 
of non alcoholic fatty liver disease (NAFLD), the most common liver disorder worldwide. 
In  this  study,  the  effects  of  high  fat  diet-induced  NAFLD  on  Coenzyme  Q  (CoQ) 
metabolism and plasma oxidative stress markers in rats were investigated. Rats were fed a 
standard low fat diet (control) or a high fat diet (57% metabolizable energy as fat) for  
18  weeks.  The  concentrations  of  total  (reduced  +  oxidized)  CoQ9  were  increased  by  
>2 fold in the plasma of animals fed the high fat diet, while those of total CoQ10 were 
unchanged. Reduced CoQ levels were raised, but oxidized CoQ levels were not, thus the 
proportion  in  the  reduced  form  was  increased  by  about  75%.  A  higher  percentage  of 
plasma CoQ9 as compared to CoQ10 was in the reduced form in both control and high fat 
fed  rats.  Plasma  protein  thiol  (SH)  levels  were  decreased  in  the  high  fat-fed  rats  as 
compared to the control group, but concentrations of lipid hydroperoxides and low density 
lipoprotein (LDL) conjugated dienes were unchanged. These results indicate that high fat 
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diet-induced  NAFLD  in  rats  is  associated  with  altered  CoQ  metabolism  and  increased 
protein, but not lipid, oxidative stress.  
Keywords: antioxidants; oxidative stress; non alcoholic fatty liver disease; Coenzyme Q; 
protein thiol groups; rats 
 
1. Introduction  
Non alcoholic fatty liver disease (NAFLD) is characterised by the accumulation of triacylglycerol 
(TG) inside liver cells. It is relatively common in the general population, with an estimated occurrence 
of 20–30%, but its incidence is greatly increased to 70–90% in obesity, type 2 diabetes and related 
metabolic diseases and it is considered to be the hepatic manifestation of the metabolic syndrome [1]. 
Although the simple hepatic steatosis seen in NAFLD is thought to be relatively benign, the condition 
sometimes progresses into more serious liver disease, including non-alcoholic steatohepatitis (NASH), 
liver fibrosis, cirrhosis, and in a few cases, hepatocellular carcinoma and liver failure [1]. Progression 
of the disease is more likely to occur in patients with metabolic diseases [2], but the factors involved 
are not well understood. Both insulin resistance and oxidative stress, however, are believed to play 
important roles [3]. 
The disturbances in liver lipid metabolism that lead to NAFLD are believed to follow from the 
development of insulin resistance, with the steatosis then in turn exacerbating the insulin resistance [1]. 
Studies showing that the severity of fat deposition in the liver is a good predictor of the likelihood of 
progression of NAFLD to NASH led to the proposal of the „two hit‟ hypothesis [4]. The accumulation 
of fat in the tissue was proposed to be the first hit which then increased the sensitivity of the liver to 
the second hits, mainly from increased oxidative stress and the release of pro-inflammatory cytokines, 
which cause the inflammation and tissue damage [4,5]. Since the hypothesis was formulated, a great 
deal  of  evidence  has  accumulated  to  support  a  role  for  oxidative  stress  in  NAFLD  [3,6].  Insulin 
resistance leads to increased oxidation in the liver, raised production of reactive oxygen species, higher 
levels of hepatic lipid peroxidation, protein oxidation and pro-inflammatory cytokine production [3,7–9] 
and decreased antioxidant capacity in the plasma [10]. In contrast, the importance of steatosis as the 
first hit is now increasingly questioned in the light of recent studies indicating that oxidative stress and 
the other proposed second hits all also cause hepatic fat deposition [11,12]. Thus, oxidative stress is 
now viewed as one of the major causes of NAFLD. 
Naturally  occurring  lipid  soluble  antioxidants  include  carotenoids,  vitamins  A  and  E  and  
Coenzyme  Q  (CoQ)  (also  called  ubiquinone).  Of  these,  CoQ  is  the  only  one  that  is  synthesised 
endogenously  in  animals.  It  is  produced  in  all  tissues  and  cells,  and  in  the  inner  mitochondrial 
membrane  it  acts  as  a  redox  carrier  in  the  respiratory  chain  [13].  It  is  present,  however,  in  all 
intracellular membranes and in plasma, and reduced CoQ is believed to function as an antioxidant to 
protect lipids from peroxidation [13]. Mitochondrial dysfunction is a feature of NAFLD [14], and a 
recent study in our laboratory has suggested that body concentrations of CoQ may be disturbed in the 
condition [15]. Int. J. Mol. Sci. 2012, 13                       
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Animal studies of NAFLD have commonly used rodents with a genetic defect or fed a diet deficient 
in choline or methionine [16]. In humans, however, the condition is usually associated with caloric 
overconsumption, and methods have now been developed to induce NAFLD in animals in a similar 
way [4,17]. Our previous work has shown that a diet containing 57% of energy from fat induces the 
characteristic features of NAFLD in rats, including insulin resistance, hypertriglyceridemia, hepatic 
steatosis and liver damage, and thus provides a suitable model for the early stages of the disease [15,18]. 
In the present study, we have used this model to test the hypothesis that CoQ metabolism is disturbed 
in  NAFLD,  using  our  previously  characterized  high  fat  diet-induced  rat  model  of  the  disease.  
In addition, we have studied the effects of NAFLD on other oxidative stress markers including protein 
SH, the antioxidants glutathione (GSH) and vitamins A (VitA) and E (VitE) in blood. 
2. Results and Discussion  
2.1. Plasma Lipids, Enzymes, Insulin and Homeostatic Model Assessment of Insulin Resistance 
(HOMA-IR) 
The concentrations of TG and cholesterol in plasma from rats given the control or high fat diet are 
shown in Figure 1. As expected, plasma TG levels were markedly increased by the high fat diet 
(Figure 1A), but plasma cholesterol concentrations were unchanged (Figure 1B). Total plasma lipids 
(TG + cholesterol) were raised by about 30% (Figure 1C).  
Figure 1. Rats were fed standard low fat diet (Control diet) or a high fat diet for 18 weeks. 
Blood samples were then collected and the concentrations of triacylglycerol (TG) (A) and 
total cholesterol (TC) (B), total lipids (TG + TC) (C) and insulin (D) in plasma were 
determined and the Homeostatic model assessment of insulin resistance (HOMA-IR) (E) 
was calculated. Data are the mean from 7 (Control diet) or 10 (High fat diet) animals and 
error bars show the SEM. ** P < 0.01, *** P < 0.001 vs. Control diet. 
 
Increased  plasma  alanine  aminotransferase  (ALT)  activity  is  considered  to  be  a  biomarker  of 
NAFLD and a predictor of disease progression [19] and an AST/ALT ratio <1 indicates that NAFLD 
is present [20]. In our experiments, plasma activity of ALT was elevated by >3 fold (P < 0.01) in high 
fat-fed as compared to control rats, while aspartate animotransferase (AST) activity was unchanged. Int. J. Mol. Sci. 2012, 13                       
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Thus, the AST:ALT ratio was decreased by about 60% after high fat diet feeding (Table 1). Plasma 
insulin levels were about 4.5 fold higher in rats fed the high fat diet than in those fed the control diet 
(Figure 1D) and the HOMA-IR was also raised by about 4.5 fold (Figure 1E). There was no significant 
change, however, in plasma glucose levels (Table 1). 
Table 1. Plasma glucose, alanine aminotransferase (ALT) and aspartate animotransferase 
(AST) levels in rats fed a standard low fat (Control diet) or a high fat diet for 18 weeks. 
Blood samples were collected and the concentration of glucose and the activity of ALT and 
AST was measured. Data are the mean ±  SEM from 6 (Control diet) or 9 (High fat diet) 
animals. ** P < 0.01, *** P < 0.001 vs. Control diet. 
Parameter  Control diet  High fat diet 
Glucose (mmol/L)  8.75 ±  0.74  8.07 ±  0.25 
ALT (U/L)  33.5 ±  4.6  111.4+19.4 ** 
AST (U/L)  52.5 ±  5.1  61.1 ±  3.9 
AST/ALT  1.65 ±  0.17  0.66 ±  0.07 *** 
2.2. Liver Lipids and Histology 
Liver TG concentrations were increased by 3.1 fold in the high fat diet as compared to the control 
diet group (control diet, 18.3 ±  4.3 mg/g liver, n = 7; high fat diet 56.8 ±  3.8 mg/g liver, n = 8,  
P < 0.001), while liver cholesterol levels were raised by 29% (control diet 32.3 ±  1.0 mg/g liver, n = 7; 
high fat diet 41.7 ±  1.9 mg/g liver, n = 10, P < 0.01). 
Liver sections from rats fed the control diet showed no visible accumulation of lipid (Figure 2A), 
but in sections obtained from animals fed the high fat diet many lipid droplets could be seen inside 
hepatocytes, and this sometimes caused the nucleus to be displaced to the periphery of the cells. 
Figure 2. Rats were fed standard low fat diet (Control diet) or a high fat diet for 18 weeks. 
Livers  were  collected  and  sections  were  stained  with  haematoxylin-eosin  (H&E).  
(A) Control diet; (B) High fat diet. Images typical of sections taken from 7 rats fed the 
control diet and 10 rats fed the high fat diet are shown. Original magnification 40× . 
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These histological changes, together with the disturbances in plasma ALT activity, ALT/AST ratio, 
insulin levels and the HOMA-IR indicate that the high fat diet-fed animals have developed a fatty liver, 
and are in agreement with our previous comprehensive characterisation of the high fat diet as a model 
for the induction of NAFLD [15].  
2.3. Coenzyme Q 
In humans and many other mammals, the side chain of CoQ has 10 isoprene residues (CoQ10), but 
the major form synthesized in rats and mice has only 9 (CoQ9) [13]. Rat plasma and tissues, however, 
also contain some CoQ10, which originates from endogenous biosynthesis and also from exogenous 
sources. The concentrations of CoQ9, CoQ10 and CoQ9 + CoQ10 in the plasma of rats fed the control 
and high fat diets are shown in Figure 3. Overall CoQ (CoQ9 + CoQ10) levels (Figure 3A) were 
significantly increased in the plasma of animals fed the high fat diet (+64%, P < 0.01), and this was 
entirely due to a >2 fold rise in CoQ9 (Figure 3B), as CoQ10 concentrations (Figure 3C) were not 
significantly changed. Thus, the ratio of CoQ9:CoQ10 increased from 0.9 to 1.6 (Figure 4). Levels of 
reduced,  but  not  oxidized,  CoQ9  +  CoQ10  were  also  markedly  raised,  and  as  a  consequence  
there was an increase of about 75% in the proportion of CoQ9 + CoQ10 found in the reduced form 
(Figure 3A).  
Figure 3. Plasma Coenzyme Q (CoQ) levels in rats fed a standard low fat (Control diet) or 
a  high  fat  diet  for  18  weeks.  Blood  samples  were  collected  and  the  concentrations  of 
reduced (RedCoQ) and oxidised (OxCoQ) CoQ9 and CoQ10 in plasma were determined. 
Total CoQ values are RedCoQ + OxCoQ. (A) CoQ (CoQ9 + CoQ10) and RedCoQ/OxCoQ; 
(B) CoQ9 and RedCoQ9/OxCoQ9; (C) CoQ10 and RedCoQ10/ OxCoQ10; Data are the 
mean from 6 (Control diet) or 10 (High fat diet) animals and error bars show the SEM.  
* P < 0.05, ** P < 0.01, *** P < 0.001 vs. Control diet. 
 Int. J. Mol. Sci. 2012, 13                       
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Figure 3. Cont. 
 
Most of the CoQ9 in the plasma of the control rats was in the reduced form (reduced:oxidized ratio 
about 14), and the proportions were not significantly changed by high fat feeding, since the levels of 
both reduced and oxidized CoQ9 were increased (Figure 3B). In contrast, in the control group plasma 
CoQ10 was mainly in the oxidized form (reduced:oxidized ratio, 0.34). Reduced CoQ10 concentrations 
were increased about 2 fold after high fat feeding, but oxidized CoQ10 levels remained unchanged, 
thus the reduced:oxidized ratio (0.87) was significantly increased. However, it remained markedly 
lower than that of CoQ9 (Figure 3C). The ratio of CoQ9:CoQ10 (Figure 4) was 3–3.5 for the reduced 
form regardless of the diet, but for oxidized CoQ it was increased from 0.1 in the control group to 0.4 
after high fat feeding, because of the increase in oxidized CoQ9 (Figure 3B). 
Figure 4. Plasma CoQ9:CoQ10 ratios in rats fed a standard low fat (Control diet) or a high 
fat diet for 18 weeks. Blood samples were collected and the concentrations of reduced 
(RedCoQ) and oxidised (OxCoQ) CoQ9 and CoQ10 in plasma were measured and the ratio 
of CoQ9:CoQ10 was calculated. Data are the mean from 6 (Control diet) or 10 (High fat 
diet) animals and error bars show the SEM. ** P < 0.01, *** P < 0.001 vs. Control diet. 
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2.4. Blood Antioxidants and Oxidative Stress Markers 
Levels of protein thiol (SH) groups in the plasma were significantly reduced in the high fat-fed as 
compared to control rats (P < 0.001) (Figure 5A). LDL conjugated diene formation in response to 
copper oxidation, however, was not significantly changed (Figure 5B). The absolute reactive oxygen 
species (dROM) values were similar in animals given the control and high fat diets (Figure 5C), but 
when the difference in lipid concentrations after high fat feeding (Figure 1) was taken into account, 
there was a significant reduction in the high fat-fed group (P < 0.01) (Figure 5D).  
Figure 5. Blood oxidative stress markers in rats fed a standard low fat (Control diet) or a 
high  fat  diet  for  18  weeks.  Blood  samples  were  collected  and  the  plasma  or  LDL 
(conjugated dienes formation in response to copper oxidation) content of (A) protein thiol 
(SH) groups; (B) conjugated dienes (Vmax ×  10
3 of propagation phase, determined using  
50  μg/mL  LDL  protein);  (C)  reactive  oxygen  species  (dROMs)  was  determined.  (D) 
dROMs/plasma lipids. Data are the mean from 6 (control diet) or 9 (High fat diet) animals 
(protein SH groups and dROMs). For conjugated dienes the mean of 5 rats in each group 
are shown. Error bars show the SEM. ** P < 0.01, *** P < 0.001 vs. Control diet. 
 
The effects of the high fat diet on other plasma antioxidant levels are shown in Figure 6. Red blood 
cell GSH and plasma VitA concentrations were not significantly changed after feeding the high fat diet 
(Figure 6A,B), but VitE levels were increased (P < 0.01) (Figure 6C). This change, however, appeared 
to be related to the increase in plasma lipid concentrations in the high fat group (Figure 1), since the 
VitE: total lipid ratio was unaffected (Figure 6D).  
In  recent  years,  oxidative  stress  has  emerged  as  an  important  factor  in  the  development  of  
NAFLD [3,6] and it is now thought to be a cause as well as a result of hepatic steatosis [7,19,21].  
In this study, we investigated changes which occur in plasma oxidative stress markers, particularly 
Coenzyme Q (CoQ), and other antioxidants in high fat-diet induced model of NAFLD in rats. The 
results showed that NAFLD causes a marked rise in the plasma content of the antioxidant CoQ which 
is accompanied by an increase in the ratio of the reduced to the oxidized form, and is also associated Int. J. Mol. Sci. 2012, 13                       
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with increased protein oxidative stress in the plasma aqueous compartment. Plasma lipid peroxidation 
and antioxidant capacity as well as LDL propensity to oxidation, however, remain unchanged. 
Figure 6. Plasma antioxidant levels in rats fed a standard low fat (Control diet) or a high 
fat diet for 18 weeks. Blood samples were collected and the concentrations of (A) Red 
blood cell glutathione (GSH) (data expressed as μmol/mL whole blood); (B) VitA; and (C) 
VitE were determined. (D) VitE/plasma lipids (μmol/mmol). Data for GSH are the mean 
from 7 (Control diet) or 9 (High fat diet) animals and those for vitamins A and E are the 
mean from 4 (control diet) or 6 (High fat diet) rats. Error bars show the SEM. ** P < 0.01 
vs. Control diet.  
 
Markedly  increased  concentrations  of  CoQ9  (the  main  form  synthesized  in  rats  in  vivo)  in  
the  plasma  and  liver  mitochondria  have  been  reported  in  rat  models  of  both  type  1  and  type  2  
diabetes [22,23] and in a mouse model of NASH [24]. This rise in endogenous synthesis is believed to 
be an adaptation to systemic oxidative stress [22,25,26]. Peroxisome proliferation in the liver in rats 
occurs in diabetes and in response to feeding high fat diets, and is known to induce CoQ synthesis 
without affecting breakdown [22,23,25]. Enhanced lipid peroxidation related to physical exercise and 
dietary factors has also been reported to lead to increased tissue levels of CoQ in rats [27].  
In the present study, we found a marked rise in CoQ (CoQ9 + CoQ10) in the plasma of the high fat 
diet-induced NAFLD rats (+64%), which was caused by an increase in the level of CoQ9 (Figure 3A), 
and thus resulted in a higher ratio of CoQ9:CoQ10 (Figure 4). The ratio of reduced:oxidized CoQ9 
was unchanged by high fat feeding as concentrations of both forms were raised (Figure 3B), but for 
CoQ10 the high fat diet increased only the reduced form, thus the reduced: oxidized CoQ10 ratio was 
higher in the high fat-fed compared to control rats (Figure 3C), and consequently there was an increase 
in the overall reduced:oxidized ratio of CoQ (Figure 3A). Thus, in addition to a rise overall CoQ in the 
plasma of the high fat diet-induced NAFLD rats, the proportion of reduced CoQ is also increased. It is 
known that reduced CoQ is the most effective antioxidant in cell membranes [13], where it protects 
phospholipids and membrane proteins from free radical-induced oxidative damage. In addition, it helps 
to  prevent  lipid  peroxidation  in  lipoproteins  in  plasma  [25].  Reduced  and  oxidized  CoQ  are 
interconvertible in the body, as the quinone/quinol group can either accept or donate electrons, and the 
antioxidant effects of the reduced form are independent of those of antioxidants of dietary origin [13]. Int. J. Mol. Sci. 2012, 13                       
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Since the rise in plasma total CoQ induced by the high fat diet in the present study was due to a >2 
fold increase in CoQ9, the main form synthesized endogenously in rats, while levels of CoQ10, the 
form  found  in  animal  fats  such  as  lard  (the  fat  supplement  in  the  high  fat  diet  used  here),  were 
unchanged (Figures 3B,C and 4), the observed increase is likely to be due to an increase in endogenous 
CoQ synthesis, rather than increased intake in the diet. Since it is known that oxidative stress caused 
by insulin resistance and fat accumulation in the liver is associated with NAFLD development, our 
findings suggest that this triggers  increased endogenous synthesis of CoQ9 and also a rise in the 
proportion in the reduced state. This adaptive response may then help to protect against a reduction in 
the antioxidant capacity of the plasma and against lipid peroxidation in the model of the early stages of 
the disease used here [15].  
Plasma  levels  of  a  range  of  oxidative  stress  markers  and  antioxidants  in  rats  with  high  fat  
diet-induced  NAFLD  were  also  determined  in  the  present  study.  Plasma  concentrations  of  the 
oxidative stress marker, hydroxalkenal, have been reported to be increased when rats were fed a high 
fat diet [28], however, other workers found no change in the levels of F2-isoprostanes after high  
fat-feeding [29]. In our experiments, there was a clear decrease of about 30% in protein SH groups in 
the plasma of the high fat-fed rats, indicating increased protein oxidative stress in the plasma aqueous 
compartment  (Figure  5A).  Plasma  conjugated  dienes  and  dROM,  however,  were  not  significantly 
changed (Figure 5B) and in fact dROM were markedly reduced (−43%, Figure 5D) when the rise in 
plasma lipids (Figure 1) was taken into account, indicating that lipid peroxidation was not increased by 
the high fat diet. The lack of effect of the high fat diet on lipid peroxidation, even though protein 
oxidative  stress  was  increased,  may  be  partly  explained  by  the  use  of  saturated  fat  as  the  fat 
supplement. However, it may also be related to changes in the metabolism of the antioxidant CoQ, as 
discussed above.  
We also found no evidence for decreased plasma antioxidant levels in the high fat-fed rats. Red 
blood cell GSH and plasma VitA concentrations were not significantly changed (Figure 6A,B) and 
plasma VitE levels were increased, rather than decreased, although this was related to the increased 
plasma lipid levels (Figure 6C,D). The different effects of the high fat diet on blood concentrations of 
the two lipophilic vitamins may be explained by their different carriers. VitE is associated with the 
plasma lipoproteins, thus the rise in its levels disappears when corrected for the increase in plasma 
lipids,  but  most  VitA  in  blood  is  bound  to  retinol  binding  protein,  and  our  results  suggest  that 
concentrations of this protein remain unchanged.  
3. Experimental Section 
3.1. Animals and Diets 
Male Wistar rats weighing approximately 200 g (6 weeks old) were obtained from Harlan, Italy  
(S. Pietro al Natisone, Italy), housed individually at a temperature of 22 ° C with a 12-h light-dark cycle 
and allowed food and water ad libitum. The studies were carried out in accordance with the guidelines 
of the European Community Council for animal care and use, and all procedures conformed strictly to 
Decree 116/92, which represents the Italian enforcement of the European Directive 86/609/ EEC.  Int. J. Mol. Sci. 2012, 13                       
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The  experimental  protocol  was approved  by  the Animal  Care  Ethics  Committee  of  the  Istituto 
Superiore di Sanità  (ISS) and, according to the national law requirement the communication of the 
study has been sent by the ISS to the Animal Welfare Office (Office VI) of the Italian Minister of 
Health (Communication Protocol Number 983/SSA/07). The animals were divided into two groups 
and fed either a standard low fat rat chow diet (4.3% fat, 10% of the metabolizable energy) (control 
diet, 7 rats) or a diet containing 35% fat (31.6% saturated fat and 3.2% unsaturated fat, 57% of the 
metabolizable energy) (Mucedola srl, Settimo Milanese, Italy) (high fat diet, 10 rats) for 18 weeks. 
The composition of the diets was as described by Cano et al. [18].  
At  the  end  of  the  experiment  all  rats  were  sacrificed  after  fasting  overnight.  Blood  samples 
collected  in  heparinized  tubes  via  heart  puncture  with  the  rats  under  terminal  anesthesia 
(Acepromazine 2.5 mg/kg + Xylazine 1–5 mg/kg im) were centrifuged (3500 rpm, 15 min, at 6 ° C) to 
obtain the plasma. Because of the labile nature of oxidative stress biomarkers, plasma was isolated 
from blood samples as soon as possible after collection and aliquots were either immediately assessed 
(reactive oxygen metabolites, dROM, and thiol groups, SH) or stored at −30 ° C prior to analysis (VitA, 
VitE, cholesterol, TG) or −80 ° C (conjugated dienes, CoQ9, CoQ10). For GSH determination, pre-
treated (see Other analytical methods, below) red blood cells were kept at −80 ° C. Livers were excised, 
washed with cold physiological saline (0.9%), and samples (200 mg) were homogenised in methanol  
(5  mL).  One  lobe  of  each  liver  was  placed  in  buffered  formalin  solution  (10%  w/v).  For 
histopathological examination, samples were embedded in paraffin and sections (approximately 2 µm 
in thickness) were cut from each tissue block using a microtome. Sections were deparaffinized in 
xylene,  rehydrated  through  a  graded  ethanol  series  and  stained  with  haematoxylin-eosin  (H&E). 
Histological examination was carried out by an investigator without knowledge of the treatments. 
Lipids were extracted by the method of Folch et al. [30].  
3.2. Determination of Conjugated Dienes 
A starting sample of 0.5 mL of plasma was used for the isolation of lipoprotein fractions by step 
ultracentrifugation according to Friedewald et al. [31], adapted for fractionation of 0.5 mL plasma 
sample in a TLA-100.2 fixed angle rotor in a Beckmann TLA-100 Tabletop Ultracentrifuge. Low 
density  lipoprotein  (LDL)  (1.006–1.063  g/mL)  was  dialyzed  overnight  against  phosphate  buffer 
solution. 50 μg LDL protein /mL was incubated with CuSO4 (final concentration, 10 μM) and conjugated 
dienes formation was assayed by measuring the absorbance at 234 nm at 30 ° C for 600 min. The 
kinetic profile parameters of LDL oxidation calculated according to Pinchuk and Lichtenberg [32] are 
reported in term of Vmax (slope of the curve in the propagation phase) (OD/min units). 
3.3. Other Analytical Methods 
The TG and cholesterol content of plasma was assayed using enzyme-based kits (BioSed S.r.l., 
Rome, Italy). Protein concentrations were determined using commercial bicinchoninic acid reagent 
(Pierce) (liver supernatants) or the method of Bradford [33]. Plasma insulin was measured by ELISA 
(Mercodia, Uppsala, Sweden), and fasting plasma glucose levels (BPC BioSed srl, Rome, Italy) and 
alanine aminotransferase (ALT) and aspartate animotransferase (AST) activities (FAR srl, Verona, 
Italy) were determined using commercial kits according to the manufacturers‟ instructions. Plasma Int. J. Mol. Sci. 2012, 13                       
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VitA, VitE, CoQ9, CoQ10 concentrations were evaluated by HPLC coupled with UV, fluorescence or 
electrochemical detection as described previously [34–36]. Total dROM and SH were evaluated using 
commercial photometric tests (dROM and SHp tests, respectively, Diacron International, GR, Italy). 
The dROM test measures lipid hydroperoxides, which are generated by the oxidative attack of ROS on 
various  lipid  substrates.  In  the  assay,  alkoxyl  and  peroxyl  radicals  produced  by  iron-catalyzed 
degradation of the plasma lipid hydroperoxides are photometrically detected after reacting (75 min at 
37  ° C)  with  a  chromogenic  alkylamine  [37].  Values  are  indicated  as  arbitrary  units  (a.u.;  
1 a.u. = 0.8 mg/L H2O2). The SHp test is based on the ability of SH to develop a colored complex 
photometrically detectable after reacting (4 min at room temperature) with 5,5'-dithiobis-2-nitrobenzoic 
acid (DTNB). The results are expressed as μmol SH/L.  
For GSH determination, whole blood was centrifuged at 2500 g at 4 ° C for 10 min; the supernatant 
was removed and the pellets of erythrocytes were washed once with cold phosphate buffered saline 
(PBS). The pellet was diluted with 4 volumes  of 6%  (w/v) of ice-cold  metaphosphoric acid, and 
centrifuged at 2000 g for 10 min at 4 °C  to remove the protein precipitate. The clear supernatants were 
then used to determine the GSH content, according to Anderson [38]. The hematocrit values did not 
significantly differ between the two rat groups and the data are expressed in terms of μmol/mL of 
whole blood. 
Significance limits were calculated using Student‟s t test with GraphPad Prism software. Changes 
were considered significant at P < 0.05. 
4. Conclusions 
Our findings indicate that high fat diet-induced NAFLD in rats leads to a marked increase in the 
plasma content of the antioxidant CoQ, and that this is entirely due to an increase in the levels of CoQ9, 
which  is  synthesised  endogenously in  rats,  rather than obtained  from  the diet.  This  rise in  CoQ9 
synthesis is likely to be an adaptive response to the oxidative stress associated with NAFLD [22,25,26]. 
In addition, protein, but not lipid, oxidative stress is increased. The increase in CoQ levels may help to 
prevent increased lipid peroxidation and to counter a reduction in antioxidants in these animals.  
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